Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb 24;20(2):85-87.
doi: 10.1177/1535759720903032. eCollection 2020 Mar-Apr.

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial

David G Vossler
Comment

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial

David G Vossler. Epilepsy Curr. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Xcopri Prescribing Information. 21 November 2019. Accessed 28 November 2019 https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf.
    1. Nakamura M, Sho JH, Shin H, Jang IS. Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons. European J Pharm. 2019;855(1):175–182. doi:10.1016/j.ejphar.2019.05.007. - PubMed
    1. Kasteleijn-Nolst DGAT, DiVentura BD, Pollard JR, et al. Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089). Neurology. 2019;93(2):e559–e567. doi:10.1212/WNL.0000000000007894. - PMC - PubMed
    1. Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-responsive trial. Lancet Neurology. 2020;19(1):38–48. doi:10.1016/S1474-4422(19)30399-0. - PubMed
    1. Costa J, Fareleira F, Ascencao R, Borges M, Sampaio C, Vaz-Carneiro A. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia. 2011;52(3):1280–1291. - PubMed

LinkOut - more resources